ATE278398T1 - Verfahren zur behandlung von viralen infektionen - Google Patents
Verfahren zur behandlung von viralen infektionenInfo
- Publication number
- ATE278398T1 ATE278398T1 AT97923598T AT97923598T ATE278398T1 AT E278398 T1 ATE278398 T1 AT E278398T1 AT 97923598 T AT97923598 T AT 97923598T AT 97923598 T AT97923598 T AT 97923598T AT E278398 T1 ATE278398 T1 AT E278398T1
- Authority
- AT
- Austria
- Prior art keywords
- protoporphyrin
- infected
- virus
- cells
- viral infections
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title abstract 2
- ZGXJTSGNIOSYLO-UHFFFAOYSA-N 88755TAZ87 Chemical compound NCC(=O)CCC(O)=O ZGXJTSGNIOSYLO-UHFFFAOYSA-N 0.000 abstract 1
- KSFOVUSSGSKXFI-GAQDCDSVSA-N CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O Chemical compound CC1=C/2NC(\C=C3/N=C(/C=C4\N\C(=C/C5=N/C(=C\2)/C(C=C)=C5C)C(C=C)=C4C)C(C)=C3CCC(O)=O)=C1CCC(O)=O KSFOVUSSGSKXFI-GAQDCDSVSA-N 0.000 abstract 1
- 229960002749 aminolevulinic acid Drugs 0.000 abstract 1
- 229950003776 protoporphyrin Drugs 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biotechnology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/646,548 US5895786A (en) | 1996-05-08 | 1996-05-08 | Method for treating viral infections |
| PCT/US1997/007811 WO1997041855A1 (en) | 1996-05-08 | 1997-05-07 | Method for treating viral infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE278398T1 true ATE278398T1 (de) | 2004-10-15 |
Family
ID=24593477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97923598T ATE278398T1 (de) | 1996-05-08 | 1997-05-07 | Verfahren zur behandlung von viralen infektionen |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US5895786A (de) |
| EP (1) | EP0904075B1 (de) |
| JP (1) | JP2000510123A (de) |
| AT (1) | ATE278398T1 (de) |
| AU (1) | AU2936597A (de) |
| CA (1) | CA2254070C (de) |
| DE (1) | DE69731083T2 (de) |
| IL (1) | IL126917A (de) |
| WO (1) | WO1997041855A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3970492B2 (ja) * | 1999-12-14 | 2007-09-05 | コスモ石油株式会社 | ピーリング用組成物 |
| KR100365151B1 (ko) * | 2000-05-08 | 2003-02-11 | 김형락 | 어류 병원성 세균과 바이러스의 감염 예방 및 치료를 위한δ-아미노레불린산의 신규한 용도 |
| KR100373147B1 (ko) * | 2000-05-10 | 2003-02-25 | 김형락 | 스쿠치카충 감염증의 치료제 |
| US6409719B1 (en) | 2000-09-18 | 2002-06-25 | Don A. Manning | Light stint implant device for treatment of long term viral infection |
| JP4754731B2 (ja) | 2001-07-31 | 2011-08-24 | コスモ石油株式会社 | 豚成育促進剤及び豚成育促進方法 |
| DE10162712A1 (de) * | 2001-12-19 | 2003-07-17 | Blutspendienst Der Landesverba | Verfahren zur Inaktivierung von Bakterien und Leukozyten in Blut oder Blutprodukten |
| FR2857264A1 (fr) * | 2003-07-09 | 2005-01-14 | Maco Pharma Sa | Procede d'inactivation photodynamique des pathogenes au moyen d'ala |
| US7311928B2 (en) * | 2003-12-09 | 2007-12-25 | Briant Burke | Topical compositions containing tea tree oil for treatment of viral lesions |
| US20060020033A1 (en) * | 2004-07-21 | 2006-01-26 | Ali Moiin | Method for treating dermatological viral infections |
| US7825153B2 (en) * | 2004-08-16 | 2010-11-02 | Ceramoptec Industries, Inc. | Photosensitizer formulations and their use |
| EP1938801A1 (de) | 2006-12-22 | 2008-07-02 | Biofrontera Bioscience GmbH | Nanoemulsion |
| JP5574329B2 (ja) * | 2010-05-06 | 2014-08-20 | 国立大学法人 岡山大学 | ミトコンドリアの蛍光染色方法 |
| CA2877232C (en) * | 2012-07-19 | 2017-08-22 | Sbi Pharmaceuticals Co., Ltd. | Prophylactic/therapeutic agent for influenza virus infection |
| GB201215675D0 (en) * | 2012-09-03 | 2012-10-17 | Univ Exeter | Compound |
| EP3011972B1 (de) * | 2013-06-19 | 2019-10-23 | SBI Pharmaceuticals Co., Ltd. | Medizinische zusammensetzung zur förderung der synthese von protoporphyrin ix |
| JPWO2016163082A1 (ja) * | 2015-04-10 | 2017-12-07 | Ｓｂｉファーマ株式会社 | Ａｌａ類を含むウイルス感染症予防／治療剤 |
| WO2020218577A1 (ja) | 2019-04-26 | 2020-10-29 | ネオファーマジャパン株式会社 | フラビウイルス感染症治療剤 |
| JP7497790B2 (ja) | 2019-12-27 | 2024-06-11 | 国立大学法人北海道大学 | 豚コレラの治療及び／又は予防剤 |
| US20230190690A1 (en) * | 2020-04-22 | 2023-06-22 | Neopharma Japan Co., Ltd. | Therapeutic and/or preventive agent for coronavirus disease 2019 (covid-19) |
| CN115916178A (zh) * | 2020-07-15 | 2023-04-04 | 日本纽翱医药股份有限公司 | 非洲猪瘟(African Swine Fever:ASF)的治疗剂和/或预防剂 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5120649A (en) * | 1990-05-15 | 1992-06-09 | New York Blood Center, Inc. | Photodynamic inactivation of viruses in blood cell-containing compositions |
| WO1994006424A1 (en) * | 1992-09-21 | 1994-03-31 | Quadra Logic Technologies, Inc. | Transcutaneous in vivo activation of photosensitive agents in blood |
| JP3955093B2 (ja) * | 1995-03-10 | 2007-08-08 | フォトキュア エイエスエイ | 光化学治療における光増感剤としての５−アミノレブリン酸のエステル |
| GB0229604D0 (en) | 2002-12-19 | 2003-01-22 | Pursuit Dynamics Plc | Improvements in or relating to pumping systems |
-
1996
- 1996-05-08 US US08/646,548 patent/US5895786A/en not_active Expired - Fee Related
-
1997
- 1997-05-07 AT AT97923598T patent/ATE278398T1/de not_active IP Right Cessation
- 1997-05-07 AU AU29365/97A patent/AU2936597A/en not_active Abandoned
- 1997-05-07 EP EP97923598A patent/EP0904075B1/de not_active Expired - Lifetime
- 1997-05-07 IL IL12691797A patent/IL126917A/en not_active IP Right Cessation
- 1997-05-07 CA CA002254070A patent/CA2254070C/en not_active Expired - Fee Related
- 1997-05-07 JP JP09540207A patent/JP2000510123A/ja active Pending
- 1997-05-07 WO PCT/US1997/007811 patent/WO1997041855A1/en active IP Right Grant
- 1997-05-07 DE DE69731083T patent/DE69731083T2/de not_active Expired - Fee Related
-
1999
- 1999-01-21 US US09/234,935 patent/US6323012B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP0904075A4 (de) | 1999-12-22 |
| JP2000510123A (ja) | 2000-08-08 |
| EP0904075A1 (de) | 1999-03-31 |
| IL126917A (en) | 2001-11-25 |
| DE69731083D1 (de) | 2004-11-11 |
| CA2254070A1 (en) | 1997-11-13 |
| DE69731083T2 (de) | 2005-09-08 |
| US5895786A (en) | 1999-04-20 |
| CA2254070C (en) | 2008-07-29 |
| US6323012B1 (en) | 2001-11-27 |
| AU2936597A (en) | 1997-11-26 |
| WO1997041855A1 (en) | 1997-11-13 |
| IL126917A0 (en) | 1999-09-22 |
| EP0904075B1 (de) | 2004-10-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE278398T1 (de) | Verfahren zur behandlung von viralen infektionen | |
| ATE298741T1 (de) | Polyaromatische verbindungen zur behandlung von herpes-infektionen | |
| DE69535758D1 (de) | Lipid-analoge zur behandlung von viralen infektionen | |
| ATE241358T1 (de) | Verwendung von cholinesterasehemmer zur behandlung von konzentrationsstörungen | |
| BRPI0213786B8 (pt) | peptídeos efetivos no tratamento de tumores e outras condições que requerem a remoção ou destruição de células | |
| ATE233738T1 (de) | Kleine moleküle anwendbar in der behandlung von entzündgskrankheiten | |
| ATE331521T1 (de) | Behandlung von schmerzen | |
| TR199802441A3 (tr) | Kanda asiri ürik asit bulunmasinin tedavisi ve önlenmesi için yöntem ve terkip. | |
| NO953995D0 (no) | Ionenolymere som anthelmintica i dyr | |
| ATE190843T1 (de) | Zubereitungen zur behandlung von impotenz, die ein alpha-1 inhibitor und ein alpha-2 inhibitor enthalten | |
| DK1237562T3 (da) | Fremgangsmåde til fremstilling af mikania-ekstrakter, som indeholder mikanolid og dihydromikanolid, og anvendelse i behandlingen af prolifererende sygdomme | |
| DE69730214D1 (de) | Zusammensetzung und verfahren zur behandlung von herpes simplex | |
| DE69818823D1 (de) | Dipohosphonsäuresalze für die behandlung von osteoporose | |
| ATE261724T1 (de) | Antikonvulsive derivate zur behandlung von posttraumatischen stresserkrankungen | |
| DE69413637T2 (de) | Verwendung von verzweigtkettigen Aminosäuren zur Herstellung eines Arzneimittels zur Behandlung von tardiver Dyskinesia | |
| EA199800819A1 (ru) | Способ лечения биполярного расстройства | |
| ATE155795T1 (de) | Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier | |
| ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
| ATE291434T1 (de) | Verwendung von angiotensin zur behandlung von krebsmetastasierung | |
| ATE295731T1 (de) | Olanzapine zur behandlung von drogenmissbrauch | |
| EA200100385A1 (ru) | Композиция и способ лечения нарушения гемостаза у субъекта (варианты) | |
| DE68908445D1 (de) | Mittel zur behandlung von lebererkrankungen. | |
| DE3585312D1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden. | |
| DE69635282D1 (de) | Behandlung der exzessiven aggressivität mit olanzapine | |
| DE69932741D1 (de) | Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |